GLP-1 Drugs Show Promise in Reducing Heart Attack Risk by 13%
Recent research has highlighted the potential of GLP-1 receptor agonists, commonly used as weight loss drugs, to reduce the risk of heart attacks and other cardiovascular events by 13%. The study, involving over 90,000 patients, found that these drugs not only aid in weight management but also offer significant cardiovascular benefits. The findings suggest that GLP-1 drugs could play a crucial role in preventing heart disease, particularly among individuals with high cardiovascular risk, type 2 diabetes, or obesity.